Your browser doesn't support javascript.
loading
Smartphone-based virtual agents and insomnia management: A proof-of-concept study for new methods of autonomous screening and management of insomnia symptoms in the general population.
Dupuy, Lucile; Morin, Charles M; de Sevin, Etienne; Taillard, Jacques; Salles, Nathalie; Bioulac, Stéphanie; Auriacombe, Marc; Micoulaud-Franchi, Jean-Arthur; Philip, Pierre.
Afiliação
  • Dupuy L; Université de Bordeaux, SANPSY USR 3413, Bordeaux, France.
  • Morin CM; CNRS, SANPSY, USR 3413, Bordeaux, France.
  • de Sevin E; École de psychologie, Université Laval, Québec, Québec, Canada.
  • Taillard J; Centre d'étude des troubles du sommeil, Centre de recherche CERVO, Institut universitaire en santé mentale de Québec, Québec, Québec, Canada.
  • Salles N; Université de Bordeaux, SANPSY USR 3413, Bordeaux, France.
  • Bioulac S; CNRS, SANPSY, USR 3413, Bordeaux, France.
  • Auriacombe M; Université de Bordeaux, SANPSY USR 3413, Bordeaux, France.
  • Micoulaud-Franchi JA; CNRS, SANPSY, USR 3413, Bordeaux, France.
  • Philip P; Université de Bordeaux, SANPSY USR 3413, Bordeaux, France.
J Sleep Res ; 31(2): e13489, 2022 04.
Article em En | MEDLINE | ID: mdl-34535942
ABSTRACT
Insomnia is the most frequent sleep disorder, and the COVID-19 crisis has massively increased its prevalence in the population, due to psychosocial stress or direct viral contamination. KANOPEE_2 is a smartphone-based application that provides interactions with a virtual agent to autonomously screen and alleviate insomnia symptoms through an intervention programme giving personalized advices regarding sleep hygiene, relaxation techniques and stimulus-control. In this proof-of-concept study, we tested the effects of KANOPEE_2 among users from all over the country (France) who downloaded the app between 1 June and 26 October 2020 (to focus on effects after the end of COVID-19 confinement). Outcome measures include insomnia severity (Insomnia Severity Index) and sleep/wake schedules measured by a sleep diary. One-thousand and thirty-four users answered the screening interview (Mage  = 43.76 years; SD = 13.14), and 108 completed the two-step programme (Mage  = 46.64 years; SD = 13.63). Of those who answered the screening, 42.8% did not report sleep complaints, while 57.2% presented mild-to-severe insomnia symptoms. At the end of the intervention, users reported significantly fewer sleep complaints compared with the beginning of the intervention (Insomnia Severity Indexbeginning  = 13.58; Insomnia Severity Indexend  = 11.30; p < 0.001), and significantly increased their sleep efficiency (sleep efficiencybeginning  = 76.46%; sleep efficiencyend  = 80.17%; p = 0.013). KANOPEE_2 is a promising solution both to provide autonomous evaluation of individuals' sleep hygiene and reduce insomnia symptoms over a brief and simple intervention. These results are very encouraging for addressing the issue of insomnia management in people exposed to major psychosocial stress and the consequences of COVID-19 infection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / COVID-19 / Distúrbios do Início e da Manutenção do Sono Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / COVID-19 / Distúrbios do Início e da Manutenção do Sono Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article